Company Search:
Advanced Search
Sponsored Links
Recordati SpA Company Snapshot
Recordati SpA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Recordati SpA with three other pharmaceutical manufacturers in Europe: Krka DD Novo Mesto of Slovenia (2017 sales of 1.27 billion Euro [US$1.43 billion] of which 61% was European Union), Vifor Pharma AG of Switzerland (1.34 billion Swiss Francs [US$1.35 billion] of which 100% was Pharmaceutical), and Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Reszvenytarsasag which is based in Hungary (444.36 billion Hungarian Forints [US$1.55 billion] of which 80% was Pharmaceutical Manufacturing and Sale).

Sales Analysis. During the year ended December of 2017, sales at Recordati SpA were 1.29 billion Euro (US$1.45 billion). This is an increase of 11.6% versus 2016, when the company's sales were 1.15 billion Euro. This was the fifth consecutive year of sales increases at Recordati SpA (and since 2012, sales have increased a total of 56%). Sales of Orphan Drugs saw an increase of 13.1% in 2017, from 186.81 million Euro to 211.24 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Recordati SpA
  Stock Performance Chart for Recordati SpA
  Stock Data: Recent Stock Performance:
  Current Price (12/14/2018): 28.60
(Figures in Euro)
1 Week 1.8%   13 Weeks -1.9%  
4 Weeks -4.6%   52 Weeks -21.8%  
Recordati SpA Key Data:
  Ticker: REC Country: Italy
  Exchanges: ISE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 1,288,123,000
(Year Ending Jan 2018).
Employees: 4,176
  Currency: Euro Market Cap: 5,827,814,307
  Fiscal Yr Ends: December Shares Outstanding: 203,769,731
  Share Type: Azioni Ordinarie Closely Held Shares: 108,305,918
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.